Picard Medical Inc

NYSE • Financial Services • Insurance - Property & Casualty • Quote as of 10/30/2026

Company Profile

IndustryInsurance - Property & Casualty

SectorFinancial Services

ExchangeNYSE

Market Capitalization18.97 mln

Float1.41 mln

Earnings Date11/13/2026

Piotroski F-Score

5 / 9

Neutral

Beneish M-Score

-9.74

Highly reliable

Relative Strength

1 / 100

Severely lagging

Debt / Equity

0.92

Moderate leverage

Pre-Tax Margin

-444%

Severely loss-making

ROE

-931

Deeply negative

Business Description

Picard Medical Inc. is a Tucson, Arizona-based medical device company founded in 2021 and operating as part of Hunniwell Picard I LLC. Its main product, the SynCardia Total Artificial Heart, is designed to replace the function of a failing human heart in patients with advanced heart failure. The company sells and distributes its products across the United States, Europe, and other international markets.

Key Fundamentals

EPS-7.77

ROE-931

RPS4.26

ROIC-97.49

ROA-205

Interest Cover-6.07

EBITDA, mln-22.66

EV / EBITDA-0.70

EV / EBIT-0.69

Revenue, mln6.30

EV / Revenue2.52

Quote Details

Last 8.35

Change 0.24 (2.96%)

Open 8.15

Volume 56,065

Turnover 468,143

Average Volume 570,283

Financial Ratios

Pre-Tax Profit Margin-444

Leverage Ratio5.34

Current Ratio1.02

Price / Book8.13

Price / Tangible Book22.03

Debt / Equity0.92

Price / Sales1.63

Financial Strength

Altman Z-Score-20.19

Piotroski F-Score 5 / 9

Beneish M-Score-9.74

Short Ratio0.13

Short % of Float3.32

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	17.77%	99 / 100
1 Month	93.29%	100 / 100
2 Months	4.38%	82 / 100
6 Months	-81.59%	1 / 100
1 Year	-98.56%	0 / 100